Cite
HARVARD Citation
Maione, P. et al. (2018). Dabrafenib plus trametinib in elderly patients (>75 years) with BRAF V600E mutated metastatic non-small-cell lung cancer: A multicenter retrospective experience from real-life. Journal of translational science. 4 (1), p. . [Online].